TECHNION RESEARCH FOR A CANCER FREE WORLD
September 24th marks World Cancer Research Day – an international awareness day to raise worldwide attention and inspire action for a cancer-free future.
The Technion’s Integrated Cancer Center is comprised of: state-of-the-art cancer research in the Rappaport Faculty of Medicine, exceptional engineering and basic science faculties, and five affiliated medical centers – including the Rambam Health Care Campus, which is adjacent to the Rappaport Faculty of Medicine and has the largest cancer facility in northern Israel and one of the largest in the country.
Technion researchers are committed to finding new diagnostic technologies, treatments and cures to create a healthier, cancer-free future.
CURE FOR MELANOMA
Patients often fail to respond to treatments for Melanoma, the deadliest form of skin cancer. However, a team led by Technion Prof. Amir Orian and Technion lecturer Dr. Emily Avitan-Hersh found two proteins that could lead to a new approach to overcoming anti-cancer drug resistance in melanoma.
TREATMENT-RESISTANT CANCER GETS FUNDING BOOST
Why does cancer therapy help some patients and not others? That is a question Technion Prof. Yuval Shaked has been trying to answer with his latest medical research backed by EU funds.
EARLY CARDIOVASCULAR DIAGNOSIS IS THE ANSWER
According to a team of researchers headed by Technion Professor Ami Aronheim, Professor Yuval Shaked, and Dr. Shimrit Avraham, early diagnosis of heart problems in cancer patients could significantly impact treatment success.
BACTERIA TO FIGHT CANCER
Prof. Naama Geva-Zatorsky’s research determines that immune effects of gut bacteria can prevent cancer. Prof. Geva Zatorsky is a member of the Technion’s Rappaport Faculty of Medicine and the Technion Integrated Cancer Center.
CANNABIS: FOR CANCER AND BEYOND
Technion Prof. Dedi Meiri is best known for his cutting-edge research into cannabis as a cancer treatment. He also investigates cannabis’ potential to treat Alzheimer’s, dementia and other neurological diseases.
COLD ATMOSPHERIC PLASMA TECHNOLOGY: THE FUTURE OF CANCER TREATMENT
Technion and Rambam Health Care Campus is progressing their research to create a Cold Atmospheric Plasma (CAP) device that can selectively fight cancer cells without damaging surrounding healthy tissue.
A FASTER WAY TO DIAGNOSE & PREDICT CANCER
Technion Prof. Daphne Weihs has found a way to diagnose aggressive cancer tumors in two hours. The next stage of her research is that “[they] may be able to find out more and predict where in the body a secondary tumor is likely to develop.”
CURING CANCER – AND SHRIMP VIRUSES
Technion Researcher Avi Schroeder is leading multiple breakthroughs to fight cancer and cure viruses. “I feel, and this is supported by research data, that in the upcoming decade, we will solve most problems with cancer treatment,” he said. “By 2030, we will reach a place where most cancer patients will be cured.” Today, he is also applying his research to find a vaccine for COVID-19.
PROMISING TUMOR-BUSTING TECHNOLOGY GETS FUNDED
After 10 years of funded research, aMoon, a health-tech fund,makes a $5 million investment in Technion Dean Marcelle Machluf’s venture to help bring her Nano-Ghost tumor-busting technology to market.
BLOOD TESTS IN YOUR OWN HOME
Ten years of research went into the creation of PixCell’s HemoScreen hematology analyzer. This enables cancer patients to have their blood tested at home. The patent pending, FDA-approved device is based on technology known as viscoelastic focusing, which was first discovered at the Technion.
With your help, Technion researchers will help create a future without cancer. Let’s give them the tools to create a healthier tomorrow for all of us!